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Abstract
Assembly and disassembly of viral capsids are essential steps in the viral life cycle. Studies on their kinetics are mostly
performed in vitro, allowing application of biochemical, biophysical and visualizing techniques. In vivo kinetics are poorly
understood and the transferability of the in vitro models to the cellular environment remains speculative. We analyzed
capsid disassembly of the hepatitis B virus in digitonin-permeabilized cells which support nuclear capsid entry and
subsequent genome release. Using gradient centrifugation, size exclusion chromatography and immune fluorescence
microscopy of digitonin-permeabilized cells, we showed that capsids open and close reversibly. In the absence of RNA,
capsid re-assembly slows down; the capsids remain disintegrated and enter the nucleus as protein dimers or irregular
polymers. Upon the presence of cellular RNA, capsids re-assemble in the nucleus. We conclude that reversible genome
release from hepatitis B virus capsids is a unique strategy different from that of other viruses, which employs irreversible
capsid destruction for genome release. The results allowed us to propose a model of HBV genome release in which the
unique environment of the nuclear pore favors HBV capsid disassembly reaction, while both cytoplasm and nucleus favor
capsid assembly.
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Introduction
Viral capsids facilitate multiple functions in the viral life cycle.
Outside the cell, they protect the enclosed viral genome against
nucleases, and in case of non-enveloped viruses they mediate
attachment and entry. For both enveloped and non-enveloped
viruses, they carry the viral genome to the site of replication where
they have to release the genome in order to allow access of
transcription and/or replication factors. After replication new
capsids have to be assembled for encapsidation of the progeny
genomes and subsequent release of mature virions. Capsids are
assigned to be metastable: early in infection they have to open,
later they have to assemble and close. Most data on stability of
capsids and kinetics of their formation and dissociation are
obtained in vitro allowing analysis by biophysical or electron
microscopical techniques (e.g. [1–5])
In vivo data on capsid disintegration are rare despite of their
importance for genome release and viability of infection. Two
different examples are Adenovirus 5 (Ad-5) capsids and the capsid
of Herpes simplex virus-1 (HSV-1). Ad-5 capsids disintegrate to
penton and hexon subunits after modification upon endocytosis
[6,7] for genome release. Capsids of HSV-1 in contrast remain
stable after release of one penton [8] which allows the injection of
the viral DNA from that opening [9].
Intensive studies on capsid assembly were performed in vitro on
capsids of the medically important Hepatitis B virus (HBV)
[1,5,10,11]. HBV infection is endemic in large parts of the world
and ,350 Mio people are chronically infected, accounting for 1
million deaths per year. HBV is an enveloped virus with an
icosahedral capsid that is composed of 240 or 180 copies of a
single protein species called core protein [12]. Within the oxidizing
environment outside the cell the two core protein subunits of a
dimer become linked by three disulfide bonds (Cys 48, 61 and 183
[13,14]). The capsid encloses the relaxed circular viral DNA
(rcDNA) [15], which is covalently attached to the viral polymerase
[16].
HBV cell entry is the limiting step that prevents infection of
most cell cultures but it can be by-passed by lipofection of
hepatoma cells with virion-derived capsids. Using this artificial
mode of capsid entry, HBV production reaches in vivo-like
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modified during natural entry or that lipofection changes their
structure in the same way. Complex interactions with the cellular
transport machinery mediate capsid translocation to the nuclear
periphery, passage through the NPC and liberation of the viral
DNA [17–19].
Transport and genome release must be highly efficient and well-
coordinated, because ,80% of virions are infection-competent in
vivo [20]. Within the nucleus, viral DNA is converted by cellular
repair mechanisms to a covalently closed circular form (cccDNA),
which is the template for viral mRNA synthesis including the RNA
pregenome. Interaction of the RNA pregenome with the viral
polymerase facilitates encapsidation into the viral capsid [21]. The
polymerase retrotranscribes RNA pregenome into the rcDNA, but
this occurs only within the capsids. This genome maturation
requires multiple phosphorylation steps within the C terminus of
the core protein [22,23]. Mature capsids (Mat-C) can either be
enveloped by the viral surface proteins in order to form virions or
they can be transported through the NPC causing amplification of
nuclear viral DNA.
Liver histology of HBV-infected individuals shows massive
intranuclear capsid accumulation. However, the number of
intranuclear viral genomes is low. Thus, it is believed that
unassembled core protein pass the NPC and assembles intranu-
clear [24].
HBV capsids exhibit predominantly a T=4 symmetry with a
diameter of ,36 nm. Core protein assembly is independent of
eukaryotic host proteins as it occurs also upon core protein
expression in E. coli resulting in ‘‘recombinant’’ capsids (rC). In
contrast to natural capsids, rC are unphosphorylated and contain
E. coli RNA [25]. In addition, they exhibit one unnatural disulfide
bond linking the C terminal Cys (C183) of one core protein with a
C183 of a neighboring dimer [26].
Structure of the first 143 aa of core proteins in rC has been
obtained by X ray crystallography with a resolution of 3.3 A ˚ [27].
The core monomer comprises two long a-helices with a hairpin
structure. Association of two hairpins from two monomers forms a
spike which protrudes from the particle surface. The connecting
loop is exposed on the spike tip and comprises the immune
dominant c/e1 B cell epitope, so that most antibodies are
conformation-dependent. While the first 143 aa of the core
protein are well structured [12], the C terminus is flexible: whereas
the C terminus is localized within capsid lumen in E. coli-expressed
capsids [28], it is exposed to the exterior in viral mature capsids
[19]. The latter observation may however indicate that capsids
dynamics increase with genome maturation.
In vitro association kinetics, performed on E. coli-expressed, C
terminally truncated core proteins (aa 149), showed that capsid
formation starts with core protein dimers. It is thought that the
dimers trimerize and the resulting hexamer nucleates capsid
assembly without accumulating further distinct populations of
capsid subassemblies [10,29]. According to the laws of thermody-
namics, disassembly could just be the inverse reaction because the
attractive forces between the subunits are weak, allowing them to
transiently dissociate and re-associate (capsid breathing) [1,5] in a
way similar to that observed for polio-, flockhouse- and
rhinoviruses [2–4]. In fact, recent in vitro evaluations showed that
chaotropic agents as urea cause disassembly down to core protein
dimers without distinguishable capsid subassemblies [30]. Several
differences of these in vitro studies with the in vivo situation deserve
attention: the C terminus, which interacts with encapsidated
nucleic acids [31] and comprises the phosphorylation sites, was
deleted in these studies; the capsids contained neither RNA nor
DNA nor the polymerase. Moreover, host factors explaining the
highly time- and site-coordinated HBV genome release were not
present.
Accounting for the poor knowledge on in vivo disassembly and
the medical importance of HBV, we evaluated the fate of HBV
capsids within the cell. As no efficient infection system exists, we
used digitonin-permeabilized cells that promote genome liberation
into the nucleus. In order to distinguish reliably between input
capsids and products of disassembly and re-assembly, we
determined antibody binding properties, density, and size of
authentic and recombinant capsids, and compared these particles
with the products of nuclear import.
Results
Overview
We characterized
32P labelled mature DNA-filled capsids from
cell culture and RNA-filled capsids from E. coli as reagents. These
capsids exhibited different densities upon Nycodenz gradient
centrifugation. DNA-filled capsids undergo a transition to a
density that resembled the RNA-filled state that correlates with
nuclear entry. We demonstrated that E. coli expressed capsids
dissociate and reassociate. Using the assembly/disassembly states
we characterized two anti core protein antibodies and found
different specificities for assembly states. These characteristics
allowed us to analyse the intracellular fates of DNA-filled capsids
by immune fluorescence microscopy.
Characterization of capsids and core proteins
Phosphorylation of both HBV virion-derived (Mat-C) and E.
coli-derived (rC) capsid species resulted in specific labelling of the
core proteins (Fig. 1A). In order to exclude that contaminant
proteins accounted for the radiolabelled 21.5 kDa band we
performed an immune precipitation using a polyclonal anti HBV
capsid antibody (DAKO Ab). This antibody does not react with
denatured core protein or core protein aggregates generated by
acidification [18]. Fig. 1B showed that the DAKO Ab completely
precipitated the 21.5 kDa band. This finding confirmed the
identity of the band as core protein and showed that no other
32P-
labelled protein co-migrated. It further indicated that all core
proteins exhibited their proper conformation after phosphoryla-
tion. To analyze whether the core proteins were assembled to
Author Summary
Viral capsids facilitate protection of the enclosed viral
genome and participate in the intracellular transport of the
genome. At the site of replication capsids have to release
the genome, but after replication new capsids have to be
assembled for encapsidation of the progeny genomes.
Detailed data on stability of capsids and kinetics of their
formation and dissociation are obtained for several viruses
in vitro, allowing biophysical or electron microscopical
techniques. These approaches, however, do not consider
the impact of cellular interaction partners. Using digitonin-
permeabilized cells which support hepadnaviral genome
release actively, we analyzed the disassembly kinetic of the
hepatitis B virus (HBV) capsid. Using different analytical
methods we found that HBV capsids disintegrate to
protein dimers which reassemble to capsids inside the
nucleus. The study provides a link between in vitro and in
vivo data showing that HBV uses a unique strategy. We
propose a model in which the unique environment of the
nuclear pore favors the disassembly reaction, while both
cytoplasm and nucleus favor assembly.
Hepatitis B Virus Capsid Disassembly
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(Fig. 1C). No disintegrated capsids or aggregated core proteins
exhibiting slower and diffuse migration were observed [18].
Phosphorylated rC (P-rC) caused a minor, slower migrating band.
The additional band is characteristic for E. coli-expressed capsids.
It is assumed that the minor band represent two capsids linked by
RNA, as RNase A-treatment reduces the slower migrating band.
The presence of this band thus indicates that the trapped RNA
was not degraded upon in vitro phosphorylation. Both capsid
species reacted with the DAKO Ab confirming their exposure of
core protein epitopes.
We next analyzed possible contaminations with nucleases in the
capsid preparations. We used
32P labelled dsDNA, ssDNA and
RNA and determined the hydrolysis after 2 h incubation at 37uC
(Fig. 1D). We observed reductions of TCA-precipitable
32Pu pt o
10.2%. As the pipetting error in this assay was determined to be
4% we assume that the nuclease activities in the capsid
preparations were not significant.
The
32P capsid preparations were analyzed by Nycodenz
gradient centrifugation. Nycodenz was chosen as it conserves
protein interactions better than any other gradient media, allowing
the recovery of functionally active protein complexes [32]. In our
hands, Nycodenz allowed the recovery of 95% of E. coli-expressed
capsids loaded, while CsCl, which is known to allow separation of
genome-containing and empty capsids - caused significant capsid
disintegration to 10% (data not shown). As Nycodenz has
properties similar to sucrose that allows a separation based on
the sedimentation coefficient. In contrast to sucrose however,
Nycodenz allows capsids to reach their equilibrium. In order to
determine sedimentation of unassembled core proteins, we
analyzed urea disintegrated capsids by centrifugation. Due to the
unphysiological disulfide bonds of the C terminal Cys upon
expression in E. coli, the assay was performed using the C183S P-
rC mutant.
Sedimenting the capsids on Nycodenz gradient resulted in a
peak of P-rC from 1.257 to 1.283 g/ml, with a maximum at
1.283 g/ml (Fig. 2A, peak (1)). The three major fractions
contained 91% of the radioactivity. P-Mat-C banded at a slightly
lower density between 1.242 and 1.284 g/ml with a maximum at
1.263 g/ml (Fig. 2B, peak (2)). The four major fractions contained
98% of the radioactivity indicating that capsids had not undergone
significant degradation during centrifugation.
Urea dissociated core proteins remained close to the top of the
gradient exhibiting a peak at 1.156 g/ml (Fig. 2C, peak (3)).
Likely, these core proteins represent dimers as it was reported
upon urea disintegration by others [30].
Despite the fact that rcDNA has a ca. 1.8 fold higher molecular
mass than RNA, the density of P-Mat-C was slightly lower. In
Nycodenz however, RNA has a higher density (1.18 g/ml) than
dsDNA (1.13 g/ml) while proteins have 1.31 g/ml in Nycodenz
[32]). Therefore, the different density distribution of Mat-C and
rC implies that the gradient medium entered capsid lumen. To test
this hypothesis we searched for Nycodenz entry by electron
microscopy. Nycodenz, an electron-rich solute, can be seen
without addition stain. Fig. 2D depicts that Nycodenz caused
20–24 nm large dots which were absent in the negative control.
The size of the stain was similar to the lumen of P-rC stained by
phospho tungstic acid, which exhibited the external diameter of
35 nm known for HBV capsids.
Antibody-binding to capsids and capsid subassemblies
We used rC capsids in order to separate capsids from core
protein dimers and capsid subassemblies. Separation was per-
formed by Superdex 75 size exclusion chromatography using
C183S rC capsids.
Separating a stock solution of C183S-rC revealed a single peak
in fractions A4 (0.85 ml) (Fig. 3A). Its appearance in the exclusion
volume of the column implies that practically all core proteins
were assembled to capsids. However, when a 20 fold lower core
protein amount was applied three peaks occurred (Fig. 3B): the
strongest peak (peak A; 51% of total protein) appeared in fraction
A3/4 (0.85 ml), which is within the exclusion limit of the column.
A small peak (B, ,3%) appeared in fraction B9 (1.73 ml) and
another stronger peak (peak C, 46%) was observed in fraction C1/
2 (1.92 ml).
Re-application of peak A after 1 h at RT resulted in the re-
appearance of peaks A, B and C (69% peak A, 10% peak B and
23% peak C; Fig. 3C). Re-injection of peak C revealed the same
peaks but with a different distribution (A 11%, B 10%, C 79%)
(Fig. 3D). This finding confirms that rC undergoes dissociation, as
described previously [1,5].
For analyzing the immune reactivity of the fractions, we used
two anti capsid antibodies: (1) polyclonal DAKO Ab reacts with
entire wt capsids but only weakly with denaturated core proteins
Figure 1. Analysis of
32P labelled capsids. A. Labelling of virion-
derived capsids (P-Mat-C) using the endogenous protein kinase (left)
and E. coli-derived capsids (rC) by in vitro phosphorylation (P-rC, right)
using SDS PAGE. m:
14C marker, labelled virion-derived capsids (P-Mat-
C), labelled E. coli-expressed capsids (P-rC). The labelling resulted in a
single 21.5 kDa band characteristic for the core protein. B. Immune
precipitation of both capsids by DAKO AB. p: precipitate, s: supernatant.
Both capsids were completely precipitated. The result shows that no
other radiolabelled 21.5 kDa protein contaminated the preparations. C.
Separation of P-Mat-C (left) and P-rC (right) on native agarose gels
followed by Western blot using DAKO Ab or phosphoimaging (
32P). The
numbers show a geometrical dilution of rC in pg, which was used for
quantification. The figures show that the labelled core proteins were
assembled to capsids. D. Nuclease activity in the capsid preparations.
32P-labelled nucleic acids were incubated for 2 h at 37uC with 50 ng of
capsids. The numbers show the % of hydrolysis based on duplicates
and depicts that no significant DNase or RNase activity was
contaminating the preparations.
doi:10.1371/journal.ppat.1000563.g001
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trifugation and electron microcopy. A–C: Nycodenz gradient
ultracentrifugation using 50 ng of capsids. The graphs show the
fractions (numbers below), their densities (right scales [g/ml] and
dotted lines) and the radioactivity of the core protein bands based on
phosphoimaging (left scales, arb. units). The autoradiographies below
depict the radiography after SDS PAGE. A. P-rC, B. P-Mat-C. C. P-rC183S
treated with 4 M urea prior to centrifugation. The figures demonstrate
that P-rC exhibited a peak at 1.283 g/ml (1) while P-Mat-C showed a
peak at 1.263 (2). core proteins from urea treated C183S P-rC migrated
with a peak density of 1.156 g/ml (3). D. Electron micrograph of P-rC.
Left panel: staining by phosphotungstic acid, middle panel: after
incubation with Nycodenz, right panel: no stain. Note that contrast on
the two right panels was enhanced as Nycodenz gives a faint contrast
only. The bar represents 50 nm. The figure shows that Nycodenz
diffuses into the capsids giving contrast within capsids lumen.
doi:10.1371/journal.ppat.1000563.g002
Figure 3. Equilibrium of capsids and capsid subassemblies.
Separation of C183S rC subassemblies on Superdex 75 PC 3.2/30
columns. A. Separation of the stock with 100 mg/50 ml, B. stock of
10 mg/50 ml. C. Reinjection of fraction A3 (peak A from Fig. 3B) after 1 h
at RT. D. Reinjection of fraction C1 (peak C from 3B) after 90 min at 4uC.
The x-axes depict the fractions, the y-axes the OD280. The panels
support the idea that capsids breathe, showing the capsid (peak A) and
two capsid subassemblies (peaks B and C). Denaturation of capsids
resulted in core proteins eluting in the flow through.
doi:10.1371/journal.ppat.1000563.g003
Hepatitis B Virus Capsid Disassembly
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to bind to an epitope on core protein dimers involving the immune
dominant loop (aa 77–80 and 83–84 [33]).
Determination of the immune reactivity of peaks A, B and C by
dot blot is shown on Fig. 4A. The graph shows the reactivity,
normalized to the protein amounts. FAb3105 reacted similarly
well with all fractions giving evidence that they contained core
proteins which were at least assembled to dimers. The polyclonal
DAKO Ab reacted best with fraction B and somewhat less with
fraction A containing the capsid. It must be considered however
that the capsid peak contains the encapsidated heterogeneous E.
coli RNA, which leads to an overestimation of the core protein
amount. Reactivity with fraction C was faint. Given that peak C
contained core proteins already assembled to dimers we conclude
that the DAKO Ab recognizes preferably epitopes that are formed
on capsid subassemblies with a higher complexity.
The interference of spike insertions with DAKO Ab binding
implies binding at or close to the spikes, similar to FAb3105. We
thus analyzed the antibody competition for their epitopes on rC.
Fig. 4B shows that preincubation with DAKO Ab completely
inhibited FAb3105 binding, suggesting overlapping binding sites.
Saturation with FAb3105 prior to DAKO Ab incubation reduced
DAKO Ab binding but not entirely, potentially due to its
polyclonality.
Nuclear import changes the density of Mat-C
In order to analyze the fate of Mat-C upon nuclear entry we
analyzed the sedimentation in Nycodenz after subjecting P-Mat-C
to nuclear import. Import reaction was performed using digitonin-
permeabilized cells, which is a well-established system for analysis
of nucleo-cytoplasmic traveling and HBV genome release at the
nuclear envelope [19,34]. A control reaction was performed by
addition of WGA, which blocks active nuclear import by nuclear
transport receptors [35]. Following import reaction, nuclei were
lysed by the same non-ionic detergents used for capsid purification
of Mat-C from secreted virus. A similar protocol was chosen to
exclude that nuclear lysis has an impact on the subsequent capsid
analysis on Nycodenz gradients.
Upon WGA inhibition, 97% of P-core proteins of the P-Mat-C
migrated as purified P-Mat-C without cell exposure, exhibiting a
peak between 1.283 and 1,252 g/ml (Fig. 5A, peak (2)) with a
maximum at 1.267 g/ml. It has been shown that P-Mat-C from
transport reaction is attached to the nuclear import receptors
Importin a and b [18]. Thus, one might expect a higher density.
However, precipitating with the DAKO Ab capsids that were
preincubated with the cytosolic extract showed, by immune blot,
that the number of coprecipitated import receptors is rather low (4
molecules per capsid, not shown). This accounts for an
undetectable increase of protein mass of ,13% only.
Core proteins derived from P-Mat-C following nuclear import
peaked between 1.304 and 1.250 g/ml with a maximum at
1.285 g/ml (Fig. 5B, peak (1)). This maximum was identical to the
one of the purified RNA-containing P-rC (1.283 g/ml). As 99% of
32P core proteins were found within these fractions we concluded
that all core proteins were assembled into particles without
exhibiting significant amounts of dimers or subassemblies. A
summary of all capsid sedimentation profiles is given in Fig. 5C.
The requirement for an active nuclear import suggested however
that the transition from ‘‘light’’ to ‘‘heavy’’ capsids occurred inside
the nucleus.
Effect of RNA on
32P-core proteins derived from nuclear
import
The changed density of the DNA-filled P-Mat-C to the density
of RNA-filled E. coli-expressed capsids upon nuclear transport
implied that the DNA genome in Mat-C was replaced by RNA.
Such a replacement likely involves at least partial capsid
disintegration, although transitory capsid subassemblies could
not be detected in our assay. Reduction of temperature or
modification of salt concentration - successfully used in biophysical
assays [1] - could not be applied as physiological nuclear import is
temperature and salt dependent. We used an alternative approach
based on the observation that HBV capsid assembly rate is
enhanced by core protein RNA-interaction [36]. We treated
digitonin-permeabilized cells by RNase A, which is a small 13.7
kDa protein that is far below the threshold of diffusion into the
nucleus (up to 68 kDa [37]). RNA degradation was monitored by
ethidium bromide staining after agarose gel electrophoresis of the
cell lysate (Fig. 6A). Specificity of degradation was shown by
control digestions using DNase I (37 kDa). DNase I treatment
however causes collapse of the nuclear structure with diffuse
distribution of the nuclear pores (not shown).
RNase A-treated cells were used for nuclear import of P-Mat-C.
Applying the nuclear lysate onto Nycodenz gradient showed two
peaks, one with densities from 1.241 to 1.300 g/ml, with a
Figure 4. Characterization of anti capsid antibodies using
capsid subassemblies. A. Immune reactivity of capsids and
subassemblies using DAKO Ab (left panel) and FAb3105 (right panel).
The graphs show the reactivity normalized to the protein amount
(arbitrary units). The fractions are given below the x-axes. The reactivity
on the y-axes is depicted in arbitrary units. The panels below are dot
blots using peaks A-C from Fig. 3B(DAKO Ab) or from Fig. 3D(Fab3105).
The graphs show that the polyclonal DAKO Ab reacts with capsids and
fraction B9, while the FAb3105 reacted with all fractions equally well. B.
Interference between DAKO Ab and FAb3105 binding to rC separation
on native agarose gel electrophoresis. 1. 1
st Ab: DAKO Ab, 2
nd Ab: horse
radish peroxidase-labelled (POD) anti rabbit. 2. 1
st Ab: FAb3105, 2
nd Ab:
POD anti mouse. 3. 1
st Ab: DAKO Ab followed by FAb3105, 2
nd Ab: POD
anti mouse. 4. 1
st Ab FAb3105 followed by DAKO Ab, 2
nd Ab: POD anti
rabbit. The blots show that preincubation with DAKO Ab totally
prevented capsid interaction with FAb3105 while preincubation with
FAb3105 inhibited DAKO Ab reactivity significantly but not completely.
doi:10.1371/journal.ppat.1000563.g004
Hepatitis B Virus Capsid Disassembly
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Mat-C after transport using 4610
6 Digitonin-permeabilized HuH-7 cells.
B. as in the upper panels but nuclear import was blocked using WGA.
Centrifugation and analysis as in Fig. 2A–C. The figures show that after
nuclear transport the capsids migrated with a peak density of 1.285 g/
ml (1) identical to the density of P-rC (Fig. 2A. Upon inhibition of
transport by WGA, the capsids exhibited a peak at 1.267 g/ml (1),
showing no difference with P-Mat-C (Fig. 2B, peak (2)). C. Superposition
of densities and capsid migration on Nycodenz gradients. The y axis
was normalized to depict the strongest signal as 100%. X axis: density in
g/ml. Bold lines: P-Mat-C (full triangles), P-Mat-C from RNase A-treated
WGA-blocked cells (full squares), P-Mat-C from WGA blocked cells (full
circles). Dotted lines: P-Mat-C from cells (open squares), P-rC (open
circles).
doi:10.1371/journal.ppat.1000563.g005
Figure 6. Effect of RNase A treatment of Digitonin-permeabi-
lized cells on Mat-C migration. A. Control of RNase A treatment by
ethidium bromide staining after agarose gel electrophoresis. m: marker,
1: cells not treated with nucleases, 2: RNase A-treated cells, 3: DNase I-
treated, 4: RNase A and DNase I-treated cells. The Figure shows that
RNase A-treatment degraded the cellular RNA completely. B. Effect of
RNase A-treatment on P-Mat-C migration on Nycodenz gradients. Upper
panels: RNase A-treated cells, lower panels: as in the upper panels but
upon inhibition of nuclear import by WGA. For legend see Fig. 2A–C. The
figures show that RNase A-treatment results in two peaks at 1.285 g/ml
(1a) and 1.156 g/ml (1b). The low density peak exhibited the same
density as urea disintegrated core proteins (Fig. 1B (3)). The high density
peak showed a similar migration as Mat-C after nuclear import with the
same peak density but with a broader range. When import was blocked
P-Mat-Cshowedamigrationwithapeak at1.266 g/ml(2)as P-Mat-Cthat
was not exposed to cells (Fig. 1B peak (2)).
doi:10.1371/journal.ppat.1000563.g006
Hepatitis B Virus Capsid Disassembly
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densities from 1.141 to 1.185 g/ml, with a maximum at 1.156 g/
ml (Fig. 6B, peak (1b)). Quantification showed that 47% of the
32P
core protein migrated in the first peak while 53% were found in
the lighter fractions. The heavier peak showed the same peak
density of P-Mat-C after nuclear import but with a broader
distribution. The lighter one showed the same distribution as urea
treated core proteins.
A control was performed by adding WGA during the import
reaction. Here, core proteins migrated with the density of P-Mat-
C, ranging from 1.242 to 1.282 g/ml (maximum 1.266 g/ml;
Fig. 4B, peak (2)), showing that RNase A has no impact on P-Mat-
C density prior to nuclear import.
Analysis of P-Mat-C using size exclusion chromatography
To confirm the presence of capsids, dimers and capsid
subassemblies, we analyzed capsids derived from nuclear import
by size exclusion chromatography. Fig. 7A (upper panel) shows the
elution profile at OD280. The peaks were derived from cellular
proteins, as the same profiles were obtained from permeabilized
cells without P-Mat-C and from RNase A-treated cells. We
analyzed the presence of
32P capsids by native agarose gel
electrophoresis (Fig. 7A, lower panels). In lysate from cells not
treated with RNase A,
32P signals were obtained in fractions A3–5
migrating as integer rC capsids.
32P-core proteins from RNase A-
treated cells, in contrast, were observed in fractions A5–7 and
exhibited a migration slower and more diffuse than rC. No core
Figure 7. Analysis of Mat-C after nuclear import by Superdex 75 columns and native agarose gel electrophoresis. A. Upper panel:
OD280 of the elution profile. The profile remained unchanged when cells were treated with RNase A. Middle panels: phosphoimager scan after native
agarose gel electrophoresis. Lower panel: phosphoimager scan after native agarose gel electrophoresis using fractions from P-Mat-C added to RNase
A-treated cells. B. Analysis of P-Mat-C from RNase A-treated cells by dot blot. Upper panel: phosphoimager scan, middle panel: detection by FAb3105,
lower panel: detection by DAKO Ab.
doi:10.1371/journal.ppat.1000563.g007
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and more complex capsid subassemblies were found. It must be
considered however, that in native agarose gel electrophoresis
unassembled core proteins migrate diffusely. Given that the signals
were already at the detection limit, diffuse bands could have
caused false negative results.
We thus analyzed the fractions derived from the RNase A-treated
cells by dot blot (Fig. 7B, upper row), revealing
32P label in fractions
C1/2 by phosphoimaging. Immune reaction of the dot blot by
FAb3105 confirmed the presence of core proteins in all the
32P-positive
fractions (Fig. 7B, middle panels). These fractions however were not
reactive with DAKO Ab, which showed a faint signal only in fraction
A8. As it overlaps with the peaks of cellular proteins, we assume that it
results from unspecific interactions, which is in accordance with the
absence of any FAb3105 or
32P label in this fraction.
Analysis of light and heavy fractions from Nycodenz
gradient centrifugation by anti capsid antibodies
Toconfirmtheimmunereactivityof thecapsids,dimersandother
capsid subassemblies, we investigated the light and the heavy
fractions derived from Nycodenz gradient centrifugation by immune
precipitation. Heavy fractions (2–5) from P-Mat-C exposed to
untreated cells (1.250–1.304 g/ml) and heavy fractions 3–5, derived
from RNase A-treated cells in which nuclear import was blocked by
WGA (1.242 to 1.282 g/ml) served as controls. From the RNase A-
treated sample, we analyzed the heavy fractions 2–5 (1.241 to
1.300 g/ml) and the light fractions of the same gradient (1.141–
1.185 g/ml). Fig. 8 depicts that FAb3105 precipitated the
32P-core
proteinsinallheavyandlightfractionsfromallgradientswithsimilar
efficiency. In contrast, DAKO Ab precipitated
32P-core proteins
only from heavy fractions of P-Mat-C from untreated cells and from
RNase A-treated cells in which nuclear import was blocked by
WGA. No precipitate was found in the heavy and light fractions
from RNase A-treated cells in which nuclear import occurred.
Intranuclear immune fluorescence of capsids and
subassemblies generated during capsid disassembly
Gradient analyses and size exclusion chromatography indicated
that P-Mat-C is subject to an RNA-dependent intranuclear
reassembly process upon nuclear import. For confirmation we
analyzed the intranuclear appearance of capsids and their
subassemblies in individual cells. Due to the lack of a suitable
infection system we used Digitonin-permeabilized cells, which are
a wide-spread technique for studying nuclear import including
HBV capsids [18,19,34]. Digitonin permeabilizes the plasma
membrane leaving the nuclear and ER membrane integer. After
addition of exogenous cargos and the addition of nuclear import
receptors the fate of the cargo can be analyzed using microscopy.
We added Mat-C and rabbit reticulocyte lysate, which is common
source of transport receptors [34]. The localization of capsids and
capsid subassemblies was determined by confocal laser scan
microscopy using indirect immune fluorescence. A control stain
was performed with propidium iodide (PI) in order to depict cell
nuclei.
Mat-C were added to permeabilized cells that were either
untreated or RNase A-treated. Controls were performed by
inhibiting nuclear import using WGA and by using cells to which
no capsids were added. Fig. 9 shows that both DAKO Ab and
FAb3105 exhibited nuclear fluorescence after addition of Mat-C
to permeabilized cells which had not been treated with RNase A.
This staining pattern is in accordance with data reported
previously in permeabilized and integer cells [17,19]. It is also in
agreement with the typical findings in liver histology [38]. The
signals of both antibodies were specific, as no fluorescences were
observed in cells to which no Mat-C was added, or in which
nuclear import was blocked by WGA [18]. In RNase A-treated
cells however, no immune fluorescence could be observed using
DAKO Ab, but strong signals were obtained using FAb3105.
These findings are in accordance with the observation that capsid
subassemblies present in the lysates from RNase A-treated cells
were not recognized by DAKO Ab but recognized by FAb3105.
FAb3105 staining in RNase A-treated cells was significantly
stronger than in cells untreated with RNase A. As both antibodies
were added together this observation is in agreement with the
competition for binding to capsids.
Discussion
Characterization of the anti capsid antibodies
Several studies describe the in vitro assembly of viral capsids, but
there are only few investigations targeting their disassembly or
their intracellular fate. In vivo investigations can hardly yield
capsids in amounts suitable for biochemical analysis. We thus used
two anti capsid antibodies and characterized at first their binding
specificity for capsid subassemblies. Both antibodies, raised against
entire capsids, are conformation-dependent. We used the well-
studied FAb3105 in order to comparatively characterize the
DAKO Ab for its reactivity against different capsid subassemblies,
obtained by separation on size exclusion columns. Comparison
was required, as the calibration of the column with globular
proteins (see Material and Methods) showed that the migration of
the subassemblies did not correspond to the MW of a single core
protein (21.5 kDa) neither to a core protein multimer, so that a
form-dependent retardation of the core proteins or unspecific
interactions with the matrix were assumed. Both subassemblies (B,
C) reacted with the FAb3105 and thus represented dimers or
larger multimeric association of core proteins. Based on the known
kinetics of HBV capsid assembly, we assume that peak C exhibits
core protein dimers and peak B corresponds to a larger assembly
state. Our experiments do not allow drawing a conclusion on how
many dimers form this complex. According to the literature
trimers of the dimers could be present in peak B, as this assembly
state was shown to be the only distinct capsid subassembly
population apart of dimers and capsids [10]. The DAKO Ab
Figure 8. Immune precipitation of light and heavy capsid
fractions from Nycodenz gradients after nuclear import of Mat-
C. Phosphoimager scan after SDS PAGE. D: precipitation by DAKO Ab, F:
precipitation by FAb3105, m: marker, C: P-Mat-C. 1: fractions 2–5 of P-
Mat-C subjected to nuclear transport (1.250–1.304 g/ml), 2: fractions 2–
5 from P-Mat-C added to RNase A-treated cells (1.241 to 1.300 g/ml), 3:
light fractions of the same gradient (1.141–1.185 g/ml), 4: fractions 3–5,
derived from RNase A-treated cells in which nuclear import was blocked
by WGA (1.242 to 1.282 g/ml). m: marker, C: core proteins. The scan
shows that FAb3105 precipitated core proteins from light and heavy
fractions. DAKO Ab, in contrast, precipitated core proteins from heavy
fractions in which capsids peaked, but not from heavy or light fraction
of RNase A-treated cells.
doi:10.1371/journal.ppat.1000563.g008
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dimer fraction (C). In fact, the faint signal obtained after blotting of
this fraction can be well explained by the limited formation of
capsid subassemblies larger than dimers occurring between harvest
from the column and blotting. We assume that the DAKO Ab
either reacts with epitopes at the interface of dimers or,
alternatively, the larger subassemblies may exhibit conformational
differences compared to free dimers, as it was suggested previously
[1].
The antibodies competed for their substrate implying that they
both attach at, or near, the capsid spikes. This was not surprising,
as the loop comprises the immune dominant c/e1 epitope of the
Figure 9. Intranuclear detection of capsids and their subassemblies after addition of Mat-C to Digitonin-permeabilized HuH-7 cells.
Indirect immune fluorescence using DAKO Ab (blue) and FAb3105 (green). To indicate the nuclei a co staining by propidium iodide (PI) was
performed (red). A: negative control without capsids, B: addition of Mat-C, C: addition of Mat-C but on RNase A-pretreated cells, D: as in B but upon
inhibition of nuclear import by WGA, E: as in C but upon WGA addition. The figure shows that upon nuclear entry in untreated cells both DAKO Ab
and FAb3105 reacted with nuclear Mat-C derived capsids. RNase A-treatment in contrast allowed detection of capsid subassemblies generated during
assembly-disassembly processes by FAb3105 but not by the DAKO Ab.
doi:10.1371/journal.ppat.1000563.g009
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DAKO Ab requires core protein assemblies larger than dimers,
and that both antibodies exhibited sterical interference. Consid-
ering the kinetics of in vitro assembly [10], it must be assumed that
the DAKO Ab reacts with core protein hexamers and fully
assembled capsids.
Distribution of capsids in density gradients
Anti capsid antibodies do not detect small amounts of core
protein monomers. For following the migration of all states of
capsids assembly on gradient we depended on sensitive and
quantitative detection. We took advantage of capsid phosphory-
lation, which allows labelling of the core proteins by radioactivity.
Phosphorylation of the capsids did not significantly affect capsid
structure, as indicated by their unaltered migration on native
agarose gel electrophoresis and their unchanged reactivity with the
DAKO Ab (not shown). This result was expected as the number of
transferred phosphates was low. In addition, data from others have
shown that E. coli-expressed capsids are identical to liver-expressed
capsids within a resolution limit of 30 A ˚ [39]. Recently these data
were confirmed with better resolution of 16 A ˚ further showing that
no gross structural changes are linked with genome maturation
and envelopment [40]. Better resolution with 10 A ˚ however
showed that a hydrophobic pocket is present on DNA-containing
capsids [41].
As these differences do not affect capsids size, the different
densities of Mat-C and rC in Nycodenz gradients suggest that the
nucleic acid content caused the difference. This assumption is in
accordance with the reported densities of RNA and dsDNA in
Nycodenz [32]. Entry of Nycodenz in the capsid lumen was
proven by electron microscopy, and could have occurred either via
the 1.5 nm-measuring holes in the capsid shell [12], or by capsid
breathing.
Effect of nuclear transport on P-Mat-C sedimentation
For analyses of the intracellular fate of HBV capsids, we
investigated the dissociation reaction of HBV capsids using
digitonin-permeabilized cells. Addition of P-Mat-C to permeabi-
lized cells caused a change of migration towards the density of
RNA containing capsids, but only upon active nuclear import.
Although the differences appear to be minor, the superposition of
the different gradients allows a clear differentiation of the
sedimentation profiles (Fig. 3B).
Strikingly, P-Mat-C showed a single density peak after nuclear
import, implying that virtually all capsids were converted, and that
no significant subpopulations failed to deliver their encapsidated
DNA into the nucleus. This high efficiency in our system suggests
that it may reflect the situation in infected individuals where up to
80% of all HBV particles are infectious [20].
Effect of nuclear RNA on nuclear capsids and capsid
subassemblies
Genome release and subsequent replacement of the genome by
RNA could hardly be explained by passage through holes in the
threefold or quasi-threefold axis of the capsid shell [12]. It can be
concluded from structural data on HBV capsids that even
dissociation of one core protein hexamer upon capsid breathing
would cause holes of only 4.3 – 5.7 nm. Further dissociation of the
capsid is probably necessary for genome release. The required
incubation period of the transport assay for obtaining detectable
nuclear import (15 min) was however much longer than the short
concentration-dependent association times of .50 s observed in
vitro [29].
To observe the disassembly of capsids into subassemblies within
nuclei we decelerated reassociation by removal of RNA. Both
sedimentation and size exclusion chromatography showed two
reaction products. The smaller product corresponded in size to
urea treated C183S P-rC by sedimentation, and to peak C of the
chromatography, thus likely representing core protein dimers.
This assumption was confirmed by their reactivity with FAb3105
and their failure to bind to the DAKO Ab following both methods
of separation.
The second product migrated similarly to RNA filled capsids,
but exhibited a slightly broader peak. Size chromatography
confirmed a similar but nevertheless different migration than
capsids, as the peak was shifted by two fractions. Further
confirmation was obtained by native agarose gel electrophoresis,
after chromatography, showing a diffuse and retarded migration
compared to capsids. Such a migration was reported for P-rC
upon acid denaturation [18] causing protein aggregation. Immune
blotting confirmed the absence of DAKO Ab reactivity arguing
against capsid or core protein hexamer formation similar to that
observed after acid denaturation. The remaining reactivity with
FAb3105 indicated however core protein dimer formation, so that
we conclude that the oligomeric reaction product consists of core
protein dimers which were assembled in a misfolded manner. In
fact, misdirected folding under preservation of intact dimer
formation was observed recently upon addition of the HBV
capsid assembly inhibitor HAP1 [42].
Localization of assembly/disassembly
To confirm the intranuclear localization of the dissociation and
reassociation events, we analyzed capsids and their subassemblies
by indirect immune fluorescence in permeabilized cells. In
accordance with gradient centrifugation and size exclusion
chromatography, we observed that RNase A-treatment generated
intranuclear subassemblies, which were reacting with FAb3105
but not with the DAKO Ab. Despite the absence of capsids, the
nuclear presence of core protein dimers indicates that RNase A
treatment did not interfere with nuclear import of core protein.
This supports the conclusion that HBV capsids become imported
into the nuclear basket as entire particles [43] but disassemble in
the nuclear environment.
In the presence of RNA, in contrast, DAKO Ab and FAb3105-
reactive assembly forms of the core protein appeared. Considering
the absence of detectable capsid subassemblies between complete
capsids and core protein dimers upon in vitro disassembly [30], this
finding implies that the capsids disintegrate to core protein dimers
followed by a rapid RNA-dependent reassociation to capsids,
which is misdirected in the absence of RNA. As we used
unphosphorylated Mat-C in this assay, these results further
exclude that phosphorylation of Mat-C has had a significant
impact on formation of capsids and on the capsid subassemblies.
Conclusions
In the present paper we showed that the dissociation of the
HBV capsid follows the in vitro association reaction in inverse
direction. Our observation that core proteins reassemble to capsids
inside the nucleus implies that both compartments - the cytoplasm
in which initial capsid formation occurs - and the nucleus, support
the assembly reaction. The environment in which disassembly
occurs should be consequently before capsid entry into the free
karyoplasm. A potential candidate compartment would be the
nuclear basket at the karyoplasmic side of the NPC, as it provides
the unique proteins of the NPC. We thus hypothesize that the
capsids assemble from core proteins via dimer and hexamer
formation, as it was proposed recently [10,29] (Fig. 10). The time
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the capsid subassemblies has to be left open but may enhance the
assembly reaction. During genome maturation and transport, the
capsid is subject to capsid breathing and remains stable [17,19,43].
Apparently, the basket of the nuclear pore comprises the
environment promoting capsid disintegration and genome liber-
ation, which occurs after arrest of the capsid [19,43]. We assume
that core protein dimers derived from disassembled capsids are
however able to diffuse deeper into the nucleus. When the
threshold concentration of nuclear core protein dimers [36] is
reached, capsid formation would occur, which is probably
enhanced by cellular RNA. As cytoplasmic capsids, they undergo
breathing but remain stable, explaining the capsid accumulation
observed in liver biopsies.
Materials and Methods
Preparation of capsids
Mat-C were prepared and purified from virions of the
permanently Hepatitis B virion-expressing hepatoma cell line
HepG2.2.15 [44] accordingly to Rabe et al [19]. The capsids of
these virions, which were shown to be infectious in chimpanzees
[45], contain viral DNA in a relaxed circular form. [44]. E. coli-
derived capsids (rC) and a mutant in which the C terminal Cys was
replaced by Ser (C183S rC) were expressed and prepared as
described previously [12]. Electron microscopy did not show any
difference between wt capsids and this mutant (not shown). While
Mat-C showed strong contamination of proteins of cell culture
medium (approx. 30 fold) both E. coli-expressed capsid prepara-
tions exhibited high purity of .90% with respect to the total
protein: SYPRO staining after SDS PAGE showed a single band
of 21.5 kDa when 400 ng were loaded. Disintegration of capsids
was achieved by treating C183S rC by 4 M urea for 10 min at
42uC.
Nuclease activities in the capsid preparation
All capsid preparations were analyzed for nuclease contamina-
tions by incubating 50 ng capsids with
32P labelled nucleic acids in
50 ml transport buffer for 2 hours at 37uC in siliconized Eppendorf
tubes and determining the amount of radioactive TCA precipi-
table material at 0 and 120 min. Five ml were removed and spotted
in duplicates on Whatman 3 M filters, dried, then immersed in a
beaker containing 300 ml 5% TCA and 1% PPi for 15 min on ice.
Filters were rinsed 3 times 5 minutes with 300 ml 5% TCA 1%
PPi, then immerged 1 minute in 70% ethanol, dried and finally
counted in a liquid scintillation counter. Radiolabelled DNA was
obtained by random priming of a 700 nt PCR product, whereas
radiolabelled RNA was obtained by T7 transcription of a
linearized plasmid containing a cloned gene downstream a T7
promoter. Radiolabelled DNA and RNA were separated from free
unincorporated nucleotide either by spin column or by ethanol
precipitation in the presence of ammonium acetate. Single
stranded DNA was obtained by 5 min heat denaturation of
DNA at 100uC followed by rapid chilling in ice.
32P labelling of capsids
Mat-C was labelled by addition of [c
32P]ATP using the activity
of the in vivo incorporated cellular protein kinase (P-Mat-C) as
described previously [19] and resulted in the transfer of 2–4 P/
capsid (T4) which corresponds to 0.008–0.017 P/core protein P.
rC and C183S rC were labelled in vitro by PKC according to Kann
et al. [26] (P-rC and P-C183S). In brief this phosphorylation
requires partial disintegration of capsid structure by low salt
treatment, followed by phosphorylation. Capsids from the stock
solution were at first diluted 1:20 in water and incubated for
15 min at 40uC. 5 mg of the diluted capsids were preincubated in
PKC buffer (20 mM HEPES pH 7.4; 10 mM MgCl2; 1.7 mM
CaCl2; 1 mM DTT) together with 3 mg phosphatidylserine for
10 min at 42uC. Then 15 ng protein kinase C (Promega) and
10 mCi [c
32P]ATP (3000 Ci/mmol) were added (5 ml final
volume) and the kinase reaction let to proceed for 30 min at
37uC, after which 0.5 ml PBS 10X was added. In contrast to the
previously reported protocol we did not performed an RNase A
digest, resulting in a 50fold reduced labelling of about 0.01 P/core
protein. After phosphorylation the capsids were reconstituted by
adjusting the salt concentration to physiological concentrations. As
we have shown previously by EM these capsids exhibit the same
structure than original capsids [26].
For separation by native agarose gel electrophoresis, capsids
were loaded on the gel using sample buffer without SDS.
Electrophoresis was performed on 1% agarose/TAE using a
TAE buffer. Blot onto PVDF membranes was performed
according to Southern [46]. Quantification of radioactivity was
performed by phosphoimaging using either Typhoon 9200
(Amersham Biosciences) or Pharos FX (BioRad). Quantification
of immune blots was performed by ECL (PerkinElmer) using
ChemiDoc XRS (BioRad).
Transport assays using digitonin-permeabilized cells
For analysis of capsid integrity during transport on Nycodenz
gradients, or on Superdex 75 PC 3.2/30 columns, 4610
6 HuH-7
cells were permeabilized by digitonin as described previously [19],
with the modification that the permeabilized cells were harvested
after the washing steps prior to the transport reaction. The
Figure 10. Schematic drawing of localization-dependent as-
sembly and disassembly of HBV capsids. Cp2: core protein dimers,
(Cp2)3: defined capsid subassemblies, (Cp2)n: core protein polymers,
Pol: polymerase, icosahedra: capsid, waved line: RNA, circles: DNA,
ellipses: section of a nuclear pore complex. For details see text.
doi:10.1371/journal.ppat.1000563.g010
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100 ml comprising 50 ng P-Mat-C and rabbit reticulocyte lysate. If
required, 100 mg/ml of wheat germ agglutinin (WGA) was added
during the washing steps. After incubation, cells were lysed using
1% NP-40/PBS/5 mM MgCl2 for 1 h at 37uC. After lysis, Triton
X-100 was added to a final concentration of 0.2%, followed by
10 min incubation at 37uC and subsequent sonification
(6615 sec). The sample of 200 ml was then subjected to analysis.
RNase A-treatment was performed for 15 min at 37uC at a final
concentration of 4 mg/ml.
Transport assays for immune detection, immune staining and
subsequent confocal laser scan microscopy were done accord-
ingly to Rabe et al. [19]. Immune staining was performed with
the polyclonal rabbit anti capsid antibody (1:200, DAKO Ab)
and with the monoclonal mouse anti capsid protein antibody
(1:200, Fab3105, Institute of Immunology CO., LTD, Tokyo,
Japan). Cy5-labelled anti rabbit antibody (1:400, Dianova) and
FITC-labelled anti mouse antibody (1:200, Dianova) served as
secondary antibodies. Nuclei were stained with propidium iodide
(1:5000).
Nycodenz gradient centrifugation
Two hundred ml of samples were added onto 3.6 ml continuous
Nycodenz/TN gradient (1.11–1.32 g/ml) in a SW60 rotor.
Centrifugation was done for 22 h at 10uC and 36,000 rpm.
Fractions of 220 ml were harvested. Density d was determined by
refractometry (s) using the formula: d=(s63,287) – 3,383. The
fractions were vortexed prior to density determination.
Size-exclusion chromatography
Capsid preparation was centrifuged for 5 min at 17 000 g
before being processed through the size-exclusion column. The
apparent molecular size of the proteins was analyzed by
chromatography on a Superdex 75 PC 3.2/30 column (GE
Healthcare), which has a fractionation range of 3 to 70 kDa. The
column was equilibrated with transport buffer (20 mM HEPES
pH 7.3, 2 mM Magnesium acetate, 110 mM Potassium acetate,
5 mM Sodium acetate, 1 mM EGTA and 1 mM DTT). Proteins
(50 ml) were eluted with a flow rate of 40 ml/min and recorded by
continuously monitoring the absorbance at 280 nm. The column
was calibrated with the following standard proteins: ovalbumin (43
kDa; 1.13 ml)), chymotrypsinogen A (25 kDa; 1.26 ml), RNase A
(13.7 kDa; 1.36 ml) and the void volume was determined with
dextran blue (.2000 kDa).
Immune blot and immune precipitations
Quantification of the capsids were done by immune blot
accordingly to Rabe et al. (11) using either the polyclonal rabbit
anti capsid antibody (1:5000, DAKO Ab) or the monoclonal
mouse anti capsid protein antibody (1:2500, Fab3105). As
secondary antibody, a horse radish peroxidase anti rabbit or anti
mouse antibody (1:10000, Dianova) were used. Detection was
performed by ECL (PerkinElmer) using ChemiDoc XRS
(BioRad). For immune precipitations 3.5610
6 sheep anti rabbit-
or anti mouse-conjugated biomagnetic beads (Dynal) were added
to 22 mg DAKO Ab or mouse anti capsid protein antibody
(Fab3105) and incubated in 0.1% BSA/PBS overnight at 4u Co n
a rotating wheel. Afterwards unbound antibodies were removed by
washing the beads three times with 0.1% BSA/PBS. The antibody
saturated beads were subjected to light and heavy capsid fractions
from Nycodenz gradients in the presence of 0.1% BSA and
incubated overnight at 37uC on a rotating wheel. The precipitate
was washed three times in 0.1% BSA/PBS, one time in 0.1%
Nonidet P-40/PBS, transferred into a new cup and again washed
three times with PBS. The samples were loaded onto a 4–12% Bis-
Tris gradient gel SDS-PAGE (NuPAGE) and transferred onto a
PVDF (VWR International) by electro blotting. Precipitated
capsid proteins were detected by their intrinsic radioactive signals
using phosphoimaging.
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